Navigation Links
NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance
Date:3/19/2008

his is part of NicOx' strategy to maximize the commercial potential and economic value of naproxcinod, as NicOx owns the global development and marketing rights to this compound. Going forward, NicOx will be looking for co-commercialization partnerships for naproxcinod, with NicOx retaining certain commercialization rights in the U.S. and selected EU markets, in order to fully exploit the drug's commercial and strategic value and to aid the Company's planned transition to a fully integrated pharmaceutical business.

James Harrison, CEO of Archimica, declared: "We are very pleased to have this opportunity to apply our expertise to the manufacturing of naproxcinod and are excited by the clear potential of this innovative product. We look forward to continuing our work with the NicOx team, and leveraging our manufacturing experience to support their timely and successful launch of naproxcinod."

NicOx is developing naproxcinod in phase 3 clinical studies, which are designed to demonstrate that it is safe, well tolerated and effective for treating the signs and symptoms of osteoarthritis, in addition to having no detrimental effect on blood pressure, in contrast to existing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). The final pivotal phase 3 trials are ongoing (the 302 and 303 studies) and the filing of a New Drug Application (NDA) for naproxcinod is projected for mid-2009.

About Archimica

Archimica is a privately held pharmaceutical fine chemicals company owned by TowerBrook Capital Partners and Aisling Capital Partners. Archimica combines first-class chemical manufacturing assets, technologies and process development with a history of pharmaceutical commercialization that stretches back over 40 years. With respect to new manufacturing projects, Archimica's strategy is focused on phase 2 and phase 3 clinical trial manufacturing opportunities for New Chemical Entities (NCEs) and this partnership with NicOx on naproxcinod is an important ex
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. NicOx Opens U.S. Headquarters in New Jersey
2. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
3. NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. Monsanto Company Signs Share Subscription Agreement With Devgen
8. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
9. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
10. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
11. Assay Designs(TM) Announces Additions to the Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) announced today ... on its board of directors. Winger is ... years of experience in corporate management, financial and ... industry perspective at an important time in the ... CEO of Nektar and member of the Board ...
(Date:12/11/2009)... Inc. (Nasdaq: ENMD ), today announced the ... sales of Thalomid® during the third quarter compared ... In addition, the Company anticipates a decrease in ... The difference in estimated and actual revenues ... the fourth quarter financial results. ,, (Logo: ...
(Date:12/11/2009)... CHESTNUT HILL, MA (12/11/2009) Boston College researchers have ... for the first time and successfully harvested the elusive ... to improved solar power efficiency, the authors report in ... . , When light is captured in solar cells, ... states. But in order to snare these charges, the ...
(Date:12/11/2009)... Dec. 11 Gwathmey, Inc., a pre-clinical ... cancer, staph aureus, and cardiovascular disease announces a ... today that Rosalie Dunn, Ph.D., has joined Gwathmey ... over 28 years of experience working with small ... joining Gwathmey, Dr. Dunn managed multimillion dollar portfolios ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3EntreMed Reports Receipt of Third Quarter Royalty Payment 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... to Aida Pharmaceuticals, ... Inc.,s Product ... (OTC Bulletin Board: AIDA) today announced that it,has signed two ... the leading microbiology research institutes in the People,s,Republic of China, ...
... Australia, March 27 Progen,Pharmaceuticals Limited (ASX: PGL; ... commercial manufacture of PI-88. The Progen,manufacturing facility at ... as,a stand-alone business providing process development services and ... transfer of,PI-88 manufacture to occur in the next ...
... Includes Equity Investment and Line of Credit -, ... Bulletin Board: MODG), a biopharmaceutical company applying its,patented ... today announced that it has closed a $2 ... and has entered into a,line of credit agreement ...
Other Biology Technology:Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the People's Republic of China 2Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the People's Republic of China 3Progen Restructures Manufacturing and Drug Discovery Divisions 2Progen Restructures Manufacturing and Drug Discovery Divisions 3Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 2Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 3Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 4Modigene Announces Closing of $12 Million Financing by Members of The Frost Group 5
(Date:12/13/2009)... to engineer plants that take advantage of elevated carbon ... help to engineer crops that take advantage of rising ... they need for photosynthesis through microscopic breathing pores in ... the gas gained, they lose hundreds of water molecules ... save water when CO 2 is abundant, but ...
(Date:12/13/2009)... The Scripps Research Institute have solved a 10-year-old ... ancient family of enzymes can have two completely ... providing guidance for understanding other molecules in the ... the protein,s possible use for combating diseases including ... published in the December 13, 2009 advance, online ...
(Date:12/11/2009)... While most school children understand that green plants ... people consider the profound global-scale effects that photosynthesis ... shedding light on the origins and evolution of ... State University,s School of Life Sciences. , Oxygen, ... such as cyanobacteria and their descendants (including algae ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Damon Runyon Cancer Research Foundation awards 242 7M to 7 top young clinical investigators 50431 1Damon Runyon Cancer Research Foundation awards 242 7M to 7 top young clinical investigators 50431 2Damon Runyon Cancer Research Foundation awards 242 7M to 7 top young clinical investigators 50431 3Damon Runyon Cancer Research Foundation awards 242 7M to 7 top young clinical investigators 50431 4Caregivers may benefit from adult day care 50428 1Caregivers may benefit from adult day care 50428 2Bladder Cancer No Longer a Death Sentence 50427 1Bladder Cancer No Longer a Death Sentence 50427 2Bladder Cancer No Longer a Death Sentence 50427 3
... the world are building an extensive repository of genetically ... function of the approximately 57,000 genes that make up ... Genomics Consortium recently announced the public availability of more ... about half of the known functional genes mapped for ...
... Tobacco isn,t famous for its health benefits. But ... tobacco plants to produce medicines for several autoimmune ... published in the open access journal BMC ... from several European research organizations have participated in ...
... Orleans, LA Research conducted by Allison Berrier, ... at the LSU Health Sciences Center New Orleans ... may help scientists design novel approaches to control ... and fibrosis. The paper, β1 Integrin Cytoplasmic Domain ...
Other Biology News:200,000 rice mutants available worldwide for scientific investigation 2Tobacco makes medicine 2Research yields potential target for cancer, wound healing and fibrosis 2Research yields potential target for cancer, wound healing and fibrosis 3
Perm/Wash Buffer 250 Tests...
Mouse monoclonal to OCIL ( Abpromise for all tested applications)....
... Large T antigen initiates replication ... replication in the presence of ... product can be used in ... Replication Kit cat. no. 8050. ...
NuParaffin Kit Application: Flow Cytometry Reactivity: Human...
Biology Products: